Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multicountry prospective clinical evaluation of two enzyme-linked immunosorbent assays and two rapid diagnostic tests for diagnosing dengue fever.
Pal S, Dauner AL, Valks A, Forshey BM, Long KC, Thaisomboonsuk B, Sierra G, Picos V, Talmage S, Morrison AC, Halsey ES, Comach G, Yasuda C, Loeffelholz M, Jarman RG, Fernandez S, An US, Kochel TJ, Jasper LE, Wu SJ. Pal S, et al. Among authors: valks a. J Clin Microbiol. 2015 Apr;53(4):1092-102. doi: 10.1128/JCM.03042-14. Epub 2015 Jan 14. J Clin Microbiol. 2015. PMID: 25588659 Free PMC article.
Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study.
Lioufas N, Toussaint ND, Pedagogos E, Elder G, Badve SV, Pascoe E, Valks A, Hawley C; IMPROVE-CKD Writing Committee.. Lioufas N, et al. Among authors: valks a. BMJ Open. 2019 Feb 21;9(2):e024382. doi: 10.1136/bmjopen-2018-024382. BMJ Open. 2019. PMID: 30796122 Free PMC article. Clinical Trial.
Aortic Calcification and Arterial Stiffness Burden in a Chronic Kidney Disease Cohort with High Cardiovascular Risk: Baseline Characteristics of the Impact of Phosphate Reduction On Vascular End-Points in Chronic Kidney Disease Trial.
Lioufas NM, Pedagogos E, Hawley CM, Pascoe EM, Elder GJ, Badve SV, Valks A, Toussaint ND; on behalf of the IMPROVE-CKD Investigators. Lioufas NM, et al. Among authors: valks a. Am J Nephrol. 2020;51(3):201-215. doi: 10.1159/000505717. Epub 2020 Feb 5. Am J Nephrol. 2020. PMID: 32023606 Clinical Trial.
A Randomized Trial on the Effect of Phosphate Reduction on Vascular End Points in CKD (IMPROVE-CKD).
Toussaint ND, Pedagogos E, Lioufas NM, Elder GJ, Pascoe EM, Badve SV, Valks A, Block GA, Boudville N, Cameron JD, Campbell KL, Chen SSM, Faull RJ, Holt SG, Jackson D, Jardine MJ, Johnson DW, Kerr PG, Lau KK, Hooi LS, Narayan O, Perkovic V, Polkinghorne KR, Pollock CA, Reidlinger D, Robison L, Smith ER, Walker RJ, Wang AYM, Hawley CM; IMPROVE-CKD Trial Investigators. Toussaint ND, et al. Among authors: valks a. J Am Soc Nephrol. 2020 Nov;31(11):2653-2666. doi: 10.1681/ASN.2020040411. Epub 2020 Sep 11. J Am Soc Nephrol. 2020. PMID: 32917784 Free PMC article. Clinical Trial.
Effect of lanthanum carbonate on serum calciprotein particles in patients with stage 3-4 CKD-results from a placebo-controlled randomized trial.
Tiong MK, Smith ER, Pascoe EM, Elder GJ, Lioufas NM, Pedagogos E, Hawley CM, Valks A, Holt SG, Hewitson TD, Toussaint ND. Tiong MK, et al. Among authors: valks a. Nephrol Dial Transplant. 2023 Feb 13;38(2):344-351. doi: 10.1093/ndt/gfac043. Nephrol Dial Transplant. 2023. PMID: 35212735 Free PMC article. Clinical Trial.
Conducting clinical trials during the COVID-19 pandemic-a collaborative trial network response.
Robison L, Cho Y, Viecelli AK, Johnson DW, Hawley CM, Valks A, Paul-Brent PA, Stastny R, Varghese J, Kiriwandeniya C, Pascoe EM, Vergara LA, Fahim MA, Boudville N, Krishnasamy R, Reidlinger D; Australasian Kidney Trials Network. Robison L, et al. Among authors: valks a. Trials. 2021 Apr 14;22(1):278. doi: 10.1186/s13063-021-05200-0. Trials. 2021. PMID: 33853661 Free PMC article.
16 results